Investigating the prognostic value of mTORC1 signaling in bladder cancer via bioinformatics evaluation
Xin Yu, Wenge Li, Shengrong Sun, Juanjuan Li · 2023
Read Investigating the prognostic value of mTORC1 signaling in bladder cancer via bioinformatics evaluation by Xin Yu, Wenge Li, Shengrong Sun, Juanjuan Li (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10716140.txt.
Description
Xin Yu and co-authors probe a growth-control pathway for clues to bladder cancer outcomes in a 2023 study. The pathway, built around a protein complex called mTORC1, steers cell growth, energy use, and immune activity, and it switches on in some bladder tumors. Using public gene, mutation, and clinical data, the team scored each tumor for pathway activity.
High scores marked patients with worse outlooks and lined up with an aggressive tumor type. Those tumors also ran hotter metabolic programs that favor cancer growth. Yet the same patients seemed to respond better to immune therapy, a useful trade-off for treatment planning. The authors built a gene signature tied to the pathway that helps forecast survival, pointing toward more personal choices in bladder cancer care.
Catalog record
| CREATOR | Xin Yu, Wenge Li, Shengrong Sun, Juanjuan Li |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |